Imaging Standards for Clinical Trials: A Picture Worth 1,000 Guidance Documents

FDA is signaling its commitment to validating surrogate endpoints by agreeing to set standards on the use of imaging techniques in clinical trials. But industry will have to wait for a definitive answer: the document isn't slated for released until 2011.